14-day Premium Trial Subscription Sign Up For FreeGet Free

No Pain, No Gain.Week 21 On Stock Market Click to watch.

Akari Therapeutics Plc Stock Forecast

NASDAQ:AKTX BUY SELL

$1.13 (0.26%)

Volume: 107.989k

Closed: May 23, 2022

Hollow Logo Score: -4.012

Akari Therapeutics Plc Stock Forecast

BUY SELL NASDAQ:AKTX
$1.13 (0.26%)

Volume: 107.989k

Closed: May 23, 2022

Score Hollow Logo -4.012

Akari Therapeutics Plc Stock Forecast NASDAQ:AKTX

Price Target and Analyst Ratings

Historical Ratings

Date Upside / Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
2020-03-13 342.48% B. Riley Securities $7.00 $5.00 Maintains Buy

AKTX Stock Trend

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled.

Given the current short-term trend, the stock is expected to fall -10.64% during the next 3 months and, with a 90% probability hold a price between $0.88 and $1.12 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Data

Date Bottom Mid Top
2022-05-25 $0.98 $1.12 $1.25
2022-05-26 $0.98 $1.11 $1.25
2022-05-27 $0.98 $1.11 $1.25
2022-05-31 $0.97 $1.11 $1.24
2022-06-01 $0.97 $1.11 $1.24
2022-06-02 $0.97 $1.10 $1.24
2022-06-03 $0.97 $1.10 $1.24
2022-06-06 $0.96 $1.10 $1.23
2022-06-07 $0.96 $1.10 $1.23
2022-06-08 $0.96 $1.09 $1.23
2022-06-09 $0.96 $1.09 $1.23
2022-06-10 $0.95 $1.09 $1.22
2022-06-13 $0.95 $1.09 $1.22
2022-06-14 $0.95 $1.08 $1.22
2022-06-15 $0.95 $1.08 $1.22
2022-06-16 $0.94 $1.08 $1.21
2022-06-17 $0.94 $1.08 $1.21
2022-06-21 $0.94 $1.07 $1.21
2022-06-22 $0.94 $1.07 $1.21
2022-06-23 $0.93 $1.07 $1.20
2022-06-24 $0.93 $1.07 $1.20
2022-06-27 $0.93 $1.06 $1.20
2022-06-28 $0.93 $1.06 $1.20
2022-06-29 $0.92 $1.06 $1.19
2022-06-30 $0.92 $1.06 $1.19
2022-07-01 $0.92 $1.05 $1.19
2022-07-05 $0.92 $1.05 $1.19
2022-07-06 $0.91 $1.05 $1.18
2022-07-07 $0.91 $1.05 $1.18
2022-07-08 $0.91 $1.04 $1.18

About Akari Therapeutics Plc

Akari Therapeutics Plc Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat rare and orphan autoimmune and inflammatory diseases. Its lead drug candidate is Coversin, a second-generation C5 complement inhibitor that is in Phase Ib clinical trial for the treatment of autoimmune and inflammatory diseases, including paroxysmal nocturnal hemoglobinuria, guillain barré syndrome, and a... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!
.

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT